Leonard L. Mazur
Net Worth

Last updated:

What is Leonard L. Mazur net worth?

The estimated net worth of Mr. Leonard L. Mazur is at least $8,219,043 as of 27 Sep 2019. He owns shares worth $2,882,763 as insider and has received compensation worth at least $5,336,280 in Citius Pharmaceuticals, Inc..

What is the salary of Leonard L. Mazur?

Mr. Leonard L. Mazur salary is $592,920 per year as Executive Chairman & Sec. in Citius Pharmaceuticals, Inc..

How old is Leonard L. Mazur?

Mr. Leonard L. Mazur is 80 years old, born in 1945.

What stocks does Leonard L. Mazur currently own?

As insider, Mr. Leonard L. Mazur owns shares in one company:

Company Title Shares Price per share Total value
Citius Pharmaceuticals, Inc. (CTXR) Executive Chairman & Sec. 2,234,700 $1.29 $2,882,763

What does Citius Pharmaceuticals, Inc. do?

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, an engineered IL-2 diphtheria toxin fusion protein for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

CTXR logo
CTXR
Citius Pharmaceuticals, Inc.
$1.29

Leonard L. Mazur insider trading

Citius Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Warrant to Purchase Common Stock 2,234,700 $3.45 $7,709,715
Purchase
Common Stock 2,234,700 $3.45 $7,709,715
Purchase
Common Stock 1,165,048 $3.45 $4,019,416
Purchase
Warrant to Purchase Common Stock 1,165,048 $3.45 $4,019,416
Purchase
Common Stock 3,137,255 $3.45 $10,823,530
Purchase
Common Stock 167,504 $3.45 $577,889
Purchase
Warrant to Purchase Common Stock 167,504 $3.45 $577,889
Purchase
Common Stock 213,106 $4.69 $999,467
Purchase
Common Stock 5,000,000 $0.6 $3,000,000

Citius Pharmaceuticals key executives

Citius Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: